Group 1: Macro Overview - The report indicates that the cyclical sector is expected to enter an expansion phase, with both cyclical and growth sectors currently in the analysts' expansion zone, resonating with the industry mainline model [3] - The report highlights that the cumulative amount of pending foreign exchange settlement funds since 2022 is approximately 1.13 trillion USD, with a weighted average exchange rate of 7.1 [2] - It is projected that the USD to RMB exchange rate will likely stabilize between 6.8 and 7.1 in 2026, with an overall upward trend but limited potential for sustained unilateral appreciation [2] Group 2: Industry Performance - The report lists the top-performing industries for January, March, and the past year, with notable performances in the oil and petrochemical sector (32.0% increase over the past year) and construction materials (42.7% increase) [1] - Conversely, the report identifies the worst-performing industries, including defense and military (-6.7% in January) and pharmaceuticals (-3.6% in January) [1] Group 3: Company Analysis - Huijia Times - Huijia Times is recognized for its competitive advantages, including a dense store network and deep local market insights, which contribute to significant scale effects and brand barriers in the Xinjiang region [6] - The company is actively upgrading its supermarket and shopping center formats and exploring innovative "low-altitude economy + consumption" scenarios, which are expected to open a second growth curve [6] - Revenue projections for Huijia Times from 2025 to 2027 are estimated at 2.422 billion, 2.557 billion, and 2.782 billion RMB, with year-on-year growth rates of 0.5%, 5.6%, and 8.8% respectively [6]

Group 1: TMT Sector - TMT theme funds experienced significant net value decline, while passive funds increased their positions in TMT theme products. The overall stock market saw fluctuations, with consumer and new energy theme funds performing well, while other theme funds struggled. A total of 24.3 billion yuan flowed out of mid and large-cap theme ETFs, while Hong Kong stock ETFs saw inflows exceeding 10 billion yuan [5]. Group 2: Metals Sector - The prices of non-ferrous metals fell across the board, but gold, tungsten, molybdenum, and vanadium prices increased month-on-month. The financing environment index for small and medium enterprises rose by 6.62% to 50.27 in January. Weekly inventory levels for hot-rolled coils were at a five-year low, while the price of oriented silicon steel hit a new low since 2018 [5][6]. Group 3: Renewable Energy and Environmental Protection - The market remains optimistic about space photovoltaic developments, with a focus on auxiliary materials and equipment. The hydrogen and ammonia sector performed well, with expectations for future carbon policies to enhance green electricity consumption. The dual control of carbon and non-electric applications is anticipated to drive supply optimization [7]. Group 4: Public Utilities - The utilization rates for wind and solar power in 2025 were 94.3% and 94.8%, respectively, both showing year-on-year declines. There is a positive outlook for non-electric applications of renewable energy and direct connections for green electricity, with recommendations to focus on companies like Electric Investment Green Energy and Jinkai New Energy [8]. Group 5: Pharmaceutical Industry - The Ministry of Industry and Information Technology and other departments issued a plan for the high-quality development of traditional Chinese medicine, aiming for a collaborative system by 2030. This policy is expected to raise compliance thresholds and enhance industry concentration, benefiting leading companies with strong integration, quality control, and research capabilities [8]. Group 6: Company Analysis - Yujian Xiaomian - Yujian Xiaomian, a leading chain of Sichuan-Chongqing flavor noodle restaurants, is expanding its national presence through a combination of direct and franchise operations. The company has shown continuous revenue growth and profitability improvements, despite challenges such as high debt and rental costs. The management team is experienced, and operational optimization is expected to further enhance profitability [9].

Group 1 - In early 2026, technology stocks are becoming a focus for institutional investors driven by sectors such as commercial aerospace, AI applications, and semiconductors [1] - Over the past month, 148 brokerages have conducted research on more than 560 listed companies, marking a 26% increase compared to the same period last year [2] - Major companies attracting attention include Daikin Heavy Industries, JinkoSolar, and Nari Technology, with Daikin leading with 49 institutional inquiries [2] Group 2 - Institutional investors are conducting in-depth inquiries focusing on industry prosperity and overseas expansion, providing key signals for future growth [3] - Daikin Heavy Industries is focusing on overseas markets for offshore wind power, particularly in Germany, Japan, the Netherlands, and Poland, which are expected to have good development prospects [4] - The emphasis on technology transfer and the challenges faced in the industry chain are becoming focal points in institutional research [5] Group 3 - JinkoSolar highlighted the advantages of perovskite solar cells in space applications, noting that solar energy density in space is 7 to 10 times higher than on Earth [6] - The research activities reflect market focus and trend expectations, although they do not directly equate to investment opportunities [6]

Group 1 - The core viewpoint of the articles highlights the active adjustment of stock ratings by brokerages in response to the performance forecasts and reports of A-share companies for 2025, indicating a positive market sentiment and potential investment opportunities [1][2] - As of February 9, 2023, brokerages have upgraded ratings for 25 stocks, with 3 receiving a "strongly recommended" rating, including Huai Bei Mining and China Duty Free Group [1] - A total of 713 stocks have been given a "buy" rating by brokerages, with notable sectors being electronics, power equipment, machinery, and automotive [1][2] Group 2 - The performance of listed companies is a significant reference for brokerage ratings, with analysts noting substantial growth in revenue for companies like DiKe Co. and Baiwei Storage, leading to "strongly recommended" ratings [3] - Brokerages are focusing on sectors with strong growth potential, such as technology (including domestic chips and semiconductor equipment), high-demand industries (like energy storage and lithium battery supply chains), and sectors benefiting from policy support (like commercial aerospace and nuclear power) [3] - The distribution of the 713 stocks with "buy" ratings includes 163 in the electronics sector, 124 in power equipment, and 112 each in machinery and automotive sectors, indicating a diverse interest across industries [2]

截至收盘，科创200指数上涨3.2%，科创100指数上涨2.8%，科创成长指数上涨2.7%，科创50指数、科创综指均上涨2.5%。Wind数据显示，科创60ETF 易方达（588080）上周连续5个交易日获资金净流入，合计近10亿元。 令日 该指数涨跌 2. 8% 该指数 滚动市盈率 2023年 207.8倍 发 科创板系列指数基本情况跟踪 (2026年2月9日) 科创50ETF易方达 低费率 跟踪上证科创板50成份指数 | 该指数由科创板中市值大、流动性 | 令日 | 该指数 | 该指数自 | | --- | --- | --- | --- | | 好的50只股票组成, "硬科技"龙 | 该指数涨跌 | 滚动市盈率 | 发布以来 | | 头特征显著,半导体占比超65%, | | | | | 与医疗器械、软件开发、光伏设备 | 2. 5% | 162.4倍 | 94. | | 行业合计占比近80% | | | | 科创100ETF易方达 【股票送3 跟踪上证科创板100指数 该指数由科创板中市值中等且流动 性较好的100只股票组成,聚焦中 小科创企业,电子、电力设备、医 药生物、计算机行业合计占比超 75%, ...

Core Viewpoint - The China Securities Medical Index (399989) closed at 7161.62 points, up 0.6%, with a trading volume of 19.192 billion yuan and a turnover rate of 1.97% on February 9 [1] Group 1: Index Performance - On the same day, 37 of the index's constituent stocks rose, with Sanbo Brain Science leading with a 5.32% increase, while 12 stocks declined, with Aier Eye Hospital falling by 2.98% [1] - The top ten constituent stocks of the China Securities Medical Index are primarily in the pharmaceutical and medical sectors, with WuXi AppTec holding the highest weight at 10.03% [1] Group 2: Stock Details - The top ten stocks include: - WuXi AppTec: Weight 10.03%, Latest Price 98.70, Market Cap 294.97 billion yuan [1] - Mindray Medical: Weight 9.12%, Latest Price 189.17, Market Cap 229.36 billion yuan [1] - United Imaging Healthcare: Weight 7.49%, Latest Price 128.92, Market Cap 106.25 billion yuan [1] - Aier Medical: Weight 6.04%, Latest Price 10.74, Market Cap 100.16 billion yuan [1] - Other notable stocks include Tigermed, Kanglong Chemical, and Yuyue Medical, all within the medical and pharmaceutical industry [1] Group 3: Capital Flow - The net outflow of main funds from the index's constituent stocks totaled 205 million yuan, while retail investors saw a net inflow of 1.51 billion yuan [1] - Detailed capital flow indicates that major stocks like WuXi AppTec and Mindray Medical experienced varying levels of net inflow and outflow from different investor categories [2]

盘后数据出炉。 沪深300今日主力资金净流入66.71亿元，创业板净流入125.74亿元。 | | | 各板块最近五个交易日主力资金净流入数据(亿元) | | | --- | --- | --- | --- | | 日期 | 沪深300 | 创业板 | 科创板 | | 2026-2-9 | 66.71 | 125.74 | -21.49 | | 2026-2-6 | -72.87 | -141.98 | -10.61 | | 2026-2-5 | -141.86 | -198.14 | -0.62 | | 2026-2-4 | -144.23 | -257.76 | -12.22 | | 2026-2-3 | -18.21 | -3.48 | -44.87 | | | | 尾盘资金净流入数据(亿元) | | | 2026-2-9 | 4.77 | 5.70 | -4.57 | | 2026-2-6 | -20.66 | -44.54 | 1.21 | | 2026-2-5 | -12.92 | -17.42 | -2.00 | | 2026-2-4 | 9.36 | 14.02 | -4.14 | | 202 ...

Market Overview - On February 9, the Shanghai Composite Index rose by 1.41%, the Shenzhen Component Index increased by 2.17%, the ChiNext Index climbed by 2.98%, and the CSI 300 Index gained 1.63% [1] - Among the tradable A-shares, 4,612 stocks rose, accounting for 84.39%, while 759 stocks declined [1] Capital Flow - The net inflow of main funds reached 33.038 billion yuan for the day [1] - The ChiNext saw a net inflow of 12.730 billion yuan, while the STAR Market had a net inflow of 1.496 billion yuan, and the CSI 300 constituents experienced a net inflow of 17.303 billion yuan [1] Industry Performance - Out of the 31 first-level industries classified by Shenwan, 31 industries rose, with the top performers being Communication and Comprehensive, which increased by 5.17% and 4.70%, respectively [1] - The Electronics industry led the net inflow of funds with 8.051 billion yuan and a daily increase of 2.97%, followed by the Computer industry with a net inflow of 6.785 billion yuan and a daily increase of 2.88% [1] Individual Stock Performance - A total of 2,310 stocks experienced net inflows, with 941 stocks having net inflows exceeding 10 million yuan, and 172 stocks with net inflows over 100 million yuan [2] - The stock with the highest net inflow was Sungrow Power Supply, which rose by 6.10% with a net inflow of 1.471 billion yuan, followed by 360 Security Technology and Newyeason with net inflows of 1.435 billion yuan and 1.307 billion yuan, respectively [2] - Conversely, 73 stocks had net outflows exceeding 100 million yuan, with Data Harbor, Hunan Gold, and CATL leading the outflows at 889 million yuan, 844 million yuan, and 769 million yuan, respectively [2]

Market Performance - The A-share market saw a collective increase in the three major indices, with the Shanghai Composite Index rising by 1.41%, the Shenzhen Component Index by 2.17%, and the ChiNext Index by 2.98% [1] - The North China 50 Index increased by 1.36% [1] - The total trading volume in the Shanghai and Shenzhen markets was approximately 22,494.73 billion yuan, an increase of about 1,037.54 billion yuan compared to the previous trading day [1] Shanxi Sector Analysis - The Shanxi sector performed steadily, with an overall increase of 0.61% and a trading volume of 120.25 billion yuan, indicating a positive market sentiment [1] - Among the 41 stocks in the Shanxi sector, 28 stocks rose, 12 fell, and 1 remained flat [1] Individual Stock Performance - Notable gainers included Jinlihua Electric and Huaxiang Co., both rising over 3%, while Dongjie Intelligent, Luhua Technology, and Huayang New Materials increased by over 2% [1] - Other stocks such as Beifang Copper Industry, Kexin Development, and Shitou Co. saw increases of over 1% [1] - Decliners included Jinkong Power and Lanyan Holdings, both dropping over 2%, while Shanxi Coking Coal and Qianyuan Pharmaceutical fell by more than 1% [1] - Several stocks, including Jinkong Coal Industry, Lu'an Environmental Energy, and Jinbo Biological, experienced milder declines, with losses contained within 1% [1]

2026 年 02 月 09 日 王睿哲 C0062@capital.com.tw 目标价(港币) 98 近期评等 | 出刊日期 | 前日收盘 | 评等 | | --- | --- | --- | | 2025/10/22 | 88.00 | 买进 | | 产品组合 | | | --- | --- | | 药品销售 | 87% | | 企业授权产品 | 12% | | 研发收入 | 1% | 股价相对大盘走势 C o m p a n y U p d a t e C h i n a R e s e a r c h D e p t . 信达生物 (01801.HK) 买进（Buy） 公司基本资讯 | 产业别 | | 医药生物 | | --- | --- | --- | | H 股价(2026/02/06) | | 79.50 | | 恒生指数(2026/02/06) | | 26560.00 | | 股价 12 个月高/低 | | 107.00 / 33.05 | | 总发行股数(百万) | | 1735.19 | | H 股数(百万) | | 1735.19 | | H 市值(亿港币) | | 1379.47 ...